PRESS RELEASEAB SCIENCE ANNOUNCES NEW PUBLICATION ON MEDRXIV HIGHLIGHTING CLINICAL BENEFIT WITH MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS ...
Additionally, NDC-011, a novel drug combination developed through DR.NOAH's AI-based drug discovery platform, received Orphan Drug Designation (ODD) from the U.S. FDA in 2023 and IND approval for a ...
ALS medication AMX0114 has been well tolerated in early clinical testing, and is now moving to a second, higher-dose trial ...
Clinical Trials Arena on MSN
FDA grants clearance to Prilenia and Ferrer’s Phase III ALS therapy trial
The study will be carried out at up to 60 ALS treatment centres across Canada, the EU, the US, Israel and the UK.
Using machine learning models, researchers at Michigan Medicine have identified a potential way to diagnose amyotrophic ...
Eric Dane is publishing a memoir about living with amyotrophic lateral sclerosis, known as ALS, the Associated Press reports.
Expansion in Asia-Pacific with second subsidiary, following Australia, pivotal to enrolling patients in phase II trial ...
The news comes eight months after Dane shared in an exclusive statement to PEOPLE that he has been diagnosed with amyotrophic ...
McCormick played a key role passing Gov. Bill Haslam's Tennessee Promise bill, which offers two-year degrees tuition-free to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback